天津招聘

Key Responsibilities主要岗位职责:
50% focus on routine testing in chemical lab, and 50% on GSKT Lean Lab project management and other projects, coordination, and implementation.
GSKT Lab OE
1. GSKT LeanLab scope: Chemical Laboratory, Micro Laboratory
2. Responsible for LeanLab projects plan, in charge of the overall programming of GSKT lean lab
3. Assure the full implementation of GSKT LeanLab projects
4. Coach the OE projects related to Laboratory
5. Improve the working efficiency of Laboratory
6. Optimize laboratory layout and become more logical
7. Improve the process capability of laboratory in order to can support better to commercial supply
8. Reduction of test items
9. Reduction of testing cycle time
10. Establish standard work flow
11. Laboratory visual management
12. Lean Documentation
13. Increase laboratory cost saving
14. Optimize other laboratory works using OE tools, i.e. Kanban, MSA
15. Communicate with group LeanLab committee and other site LeanLab experts
16. Periodic LeanLab status check using “ABCD” checklist


Specialized Knowledge 专业知识:
？ University graduate or higher in Pharmaceutical or related area.
？ Minimum 3 years experience in Pharmaceutical or biological company.
？ Knowledge of GMP, GLP and pharmacopoeia e.g.USP, EP. CP.
？ Master chemical professional skill.
？ Master analytical equipment operational and general maintenance skill.
？ Good English listening, reading and writing skills.
？ Proven good computer skills.
？ Good interpersonal co-operator and communication skills.
？ Preferable understanding of organization structure, business operation and company culture of GSK.
？ Good initiative
？ Leadership potential
Besides the above technical knowledge of laboratory analysis and operations, this position also requires the individual to have a good command of OE and lean lab principles and knowledge. This role requires strong leadership capabilities to interact with OE experts in the GMS network, section supervisors and lab analysts.

葛兰素史克制药(苏州)有限公司是由葛兰素史克集团在苏州工业园区独资建造的现代化医药生产基地，该项目注册资金为1亿3千5百万美元，是葛兰素史克集团目前在华投资最大的项目，同时也是目前国内最大规模的外商投资制药企业。